Growth Metrics

SCWorx (WORX) Research & Development (2019)

SCWorx recorded quarterly Research & Development of $198450.0 in Q3 2019, down 58.48% quarter-over-quarter from $477950.0 in Q2 2019.

SCWorx's Research & Development history runs 1 years deep, the most recent figure standing at $198450.0 for Q3 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn 198.79 Mn
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn -
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn 67.77 Mn
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn 30.34 Mn
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn 39.11 Mn
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn 18.37 Mn
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn 56.85 Mn
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn -
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn 21.52 Mn
10 SCWorx - - 374,109.00 -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2019 198,450.00
Jun 30, 2019 477,950.00
Mar 31, 2019 182,339.00